BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32083833)

  • 1. Stimuli-Responsive Polysaccharide Enveloped Liposome for Targeting and Penetrating Delivery of survivin-shRNA into Breast Tumor.
    Chen H; Fan X; Zhao Y; Zhi D; Cui S; Zhang E; Lan H; Du J; Zhang Z; Zhang S; Zhen Y
    ACS Appl Mater Interfaces; 2020 May; 12(19):22074-22087. PubMed ID: 32083833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
    Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
    Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
    Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
    Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redox-sensitive and hyaluronic acid functionalized liposomes for cytoplasmic drug delivery to osteosarcoma in animal models.
    Chi Y; Yin X; Sun K; Feng S; Liu J; Chen D; Guo C; Wu Z
    J Control Release; 2017 Sep; 261():113-125. PubMed ID: 28666726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dendronized hyaluronic acid-docetaxel conjugate as a stimuli-responsive nano-agent for breast cancer therapy.
    Wang W; Zhang X; Li Z; Pan D; Zhu H; Gu Z; Chen J; Zhang H; Gong Q; Luo K
    Carbohydr Polym; 2021 Sep; 267():118160. PubMed ID: 34119134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
    Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
    Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronan Reduces Cationic Liposome-Induced Toxicity and Enhances the Antitumor Effect of Targeted Gene Delivery in Mice.
    Qian Y; Liang X; Yang J; Zhao C; Nie W; Liu L; Yi T; Jiang Y; Geng J; Zhao X; Wei X
    ACS Appl Mater Interfaces; 2018 Sep; 10(38):32006-32016. PubMed ID: 30156827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid modified pH-sensitive liposomes for targeted intracellular delivery of doxorubicin.
    Paliwal SR; Paliwal R; Agrawal GP; Vyas SP
    J Liposome Res; 2016 Dec; 26(4):276-87. PubMed ID: 26784587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of cisplatin sensitivity in lung cancer xenografts by liposome-mediated delivery of the plasmid expressing small hairpin RNA targeting Survivin.
    Tian H; Liu S; Zhang J; Zhang S; Cheng L; Li C; Zhang X; Dail L; Fan P; Dai L; Yan N; Wang R; Wei Y; Deng H
    J Biomed Nanotechnol; 2012 Aug; 8(4):633-41. PubMed ID: 22852473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smart nanoparticles with a detachable outer shell for maximized synergistic antitumor efficacy of therapeutics with varying physicochemical properties.
    Yin T; Liu J; Zhao Z; Dong L; Cai H; Yin L; Zhou J; Huo M
    J Control Release; 2016 Dec; 243():54-68. PubMed ID: 27702595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox-Responsive and Dual-Targeting Hyaluronic Acid-Methotrexate Prodrug Self-Assembling Nanoparticles for Enhancing Intracellular Drug Self-Delivery.
    Zhang Y; Li Y; Tian H; Zhu Q; Wang F; Fan Z; Zhou S; Wang X; Xie L; Hou Z
    Mol Pharm; 2019 Jul; 16(7):3133-3144. PubMed ID: 31198046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.
    Zuo J; Jiang Y; Zhang E; Chen Y; Liang Z; Zhu J; Zhao Y; Xu H; Liu G; Liu J; Wang W; Zhang S; Zhen Y
    Life Sci; 2019 Jun; 227():145-152. PubMed ID: 31009625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
    Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
    Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral delivery of shRNA based on amino acid modified chitosan for improved antitumor efficacy.
    Zheng H; Tang C; Yin C
    Biomaterials; 2015 Nov; 70():126-37. PubMed ID: 26310108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo.
    Seraj S; Lee J; Ahn HJ
    Biochem Pharmacol; 2019 Aug; 166():192-202. PubMed ID: 31129050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a carrier system containing hyaluronic acid and protamine for siRNA delivery in the treatment of melanoma.
    Yang J; Zhao R; Feng Q; Zhuo X; Wang R
    Invest New Drugs; 2021 Feb; 39(1):66-76. PubMed ID: 32794135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanohybrid magnetic liposome functionalized with hyaluronic acid for enhanced cellular uptake and near-infrared-triggered drug release.
    Nguyen VD; Zheng S; Han J; Le VH; Park JO; Park S
    Colloids Surf B Biointerfaces; 2017 Jun; 154():104-114. PubMed ID: 28329728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of Bone- and CD44-Dual-Targeting Redox-Sensitive Liposomes for the Treatment of Orthotopic Osteosarcoma.
    Feng S; Wu ZX; Zhao Z; Liu J; Sun K; Guo C; Wang H; Wu Z
    ACS Appl Mater Interfaces; 2019 Feb; 11(7):7357-7368. PubMed ID: 30682240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.